Integra Lifesciences Holdings (IART) Change in Cash (2009 - 2026)

Integra Lifesciences Holdings (IART) has 18 years of Change in Cash data on file, last reported at $1.8 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 124.22% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at -$2.3 million (up 99.35% YoY), and the FY2025 full-year result was -$11.3 million, up 62.28% from the prior year.
• Change in Cash eased to $1.8 million in Q1 2026, from $2.9 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $315.5 million in Q1 2024 to a low of -$376.7 million in Q2 2024.
• A 5-year average of -$16.3 million and a median of $1.8 million in 2026 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash tumbled 20739.45% in 2024 and jumped 18165.82% in 2025, its largest moves.
• Tracing IART's Change in Cash over 5 years: stood at -$55.3 million in 2022, then surged by 104.83% to $2.7 million in 2023, then soared by 1069.21% to $31.2 million in 2024, then plunged by 90.83% to $2.9 million in 2025, then sank by 38.47% to $1.8 million in 2026.
• Business Quant data shows IART's Change in Cash at $1.8 million in Q1 2026, $2.9 million in Q4 2025, and $14.3 million in Q3 2025.